Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| Royalty Pharma | 2.17% | $16.99M | $23.33B | 26.48% | 79 Outperform | |
| Lockheed Martin | 1.82% | $14.25M | $138.21B | 35.43% | 70 Outperform | |
| Verizon | 1.80% | $14.12M | $166.17B | 0.86% | 81 Outperform | |
| Amdocs | 1.76% | $13.85M | $8.83B | -7.31% | 69 Neutral | |
| Johnson & Johnson | 1.75% | $13.71M | $548.64B | 48.68% | 78 Outperform | |
| AT&T | 1.73% | $13.58M | $170.64B | 4.62% | 71 Outperform | |
| L3Harris Technologies | 1.69% | $13.24M | $67.40B | 67.89% | 70 Neutral | |
| RTX | 1.66% | $13.02M | $267.43B | 54.97% | 74 Outperform | |
| Cisco Systems | 1.65% | $12.98M | $311.98B | 29.70% | 77 Outperform | |
| Walmart | 1.61% | $12.63M | $929.08B | 19.02% | 78 Outperform |